Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (24)

2023

  1. Altered Red Blood Cell Fatty Acid and Serum Adipokine Profiles in Subjects with Obesity

    Biomedicines, Vol. 11, Núm. 12

2021

  1. Effects of pterostilbene on diabetes, liver steatosis and serum lipids

    Current Medicinal Chemistry, Vol. 28, Núm. 2, pp. 238-252

  2. Gut microbiota induced by pterostilbene and resveratrol in high‐fat‐high‐fructose fed rats: Putative role in steatohepatitis onset

    Nutrients, Vol. 13, Núm. 5

  3. Inter-Individual Variability in Insulin Response after Grape Pomace Supplementation in Subjects at High Cardiometabolic Risk: Role of Microbiota and miRNA

    Molecular Nutrition and Food Research, Vol. 65, Núm. 2

  4. Potential relationship between the changes in circulating micrornas and the improvement in glycaemic control induced by grape pomace supplementation

    Foods, Vol. 10, Núm. 9

2019

  1. Effects of resveratrol and its analogue pterostilbene, on NOV/CCN3 adipokine in adipose tissue from rats fed a high-fat high-sucrose diet

    Journal of Physiology and Biochemistry, Vol. 75, Núm. 3, pp. 275-283

2018

  1. Characterization and in vitro evaluation of seaweed species as potential functional ingredients to ameliorate metabolic syndrome

    Journal of Functional Foods, Vol. 46, pp. 185-194

  2. Involvement of 5′-activated protein kinase (AMPK) in the effects of resveratrol on liver steatosis

    International Journal of Molecular Sciences, Vol. 19, Núm. 11

  3. Resveratrol and pterostilbene, two analogue phenolic compounds, affect aquaglyceroporin expression in a different manner in adipose tissue

    International Journal of Molecular Sciences, Vol. 19, Núm. 9

2017

  1. Antiobesity effects of resveratrol: Which tissues are involved?

    Annals of the New York Academy of Sciences, Vol. 1403, Núm. 1, pp. 118-131

  2. Are miRNA-103, miRNA-107 and miRNA-122 involved in the prevention of liver steatosis induced by resveratrol?

    Nutrients, Vol. 9, Núm. 4

  3. Phenolic compounds apigenin, hesperidin and kaempferol reduce in vitro lipid accumulation in human adipocytes

    Journal of Translational Medicine, Vol. 15, Núm. 1

  4. Resveratrol-induced effects on body fat differ depending on feeding conditions

    Molecules, Vol. 22, Núm. 12

2016

  1. Anti-obesity effects of resveratrol: comparison between animal models and humans

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 417-429

  2. Dietary Phenolic Compounds Interfere with the Fate of Hydrogen Peroxide in Human Adipose Tissue but Do Not Directly Inhibit Primary Amine Oxidase Activity

    Oxidative Medicine and Cellular Longevity, Vol. 2016

  3. Erratum to: MicroRNAs involved in the browning process of adipocytes (Journal of Physiology and Biochemistry, 10.1007/s13105-015-0459-z)

    Journal of Physiology and Biochemistry

  4. MicroRNAs involved in the browning process of adipocytes

    Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 509-521

2015

  1. Potential application of non-flavonoid phenolics in diabetes: Antiinflammatory effects

    Current Medicinal Chemistry, Vol. 22, Núm. 1, pp. 112-131

2014

  1. Fatty acid synthase methylation levels in adipose tissue: Effects of an obesogenic diet and phenol compounds

    Genes and Nutrition, Vol. 9, Núm. 4

  2. The combination of resveratrol and conjugated linoleic acid attenuates the individual effects of these molecules on triacylglycerol metabolism in adipose tissue

    European Journal of Nutrition, Vol. 53, Núm. 2, pp. 575-582